XML 18 R7.htm IDEA: XBRL DOCUMENT v3.20.4
Interim Condensed Consolidated Statements Of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income/(Loss)
Total Stockholders' Equity - Dolby Laboratories, Inc.
Controlling Interest
Class A Common Stock [Member]
Common Stock
Class A Common Stock [Member]
Additional Paid-In Capital
Beginning balance (in shares) at Sep. 27, 2019   99,000              
Beginning balance at Sep. 27, 2019 $ 2,313,030   $ 0 $ 2,327,877 $ (20,625) $ 2,307,351 $ 5,679    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 48,591     48,753   48,753 (162)    
Other comprehensive income, net of tax 2,742       2,565 2,565 177    
Distributions to controlling interest (283)           283    
Stock-based compensation expense 22,614   22,614     22,614      
Shares repurchased (in shares)   0              
Repurchase of common stock (30,003)   (26,705) (3,298)   (30,003)      
Cash dividends declared and paid on common stock (22,081)     (22,081)   (22,081)      
Common stock issued under employee stock plans (in shares)               0  
Common stock issued under employee stock plans 24,373   24,373     24,373      
Tax withholdings on vesting of restricted stock (in shares)               0  
Tax withholdings on vesting of restricted stock (20,282)         (20,282) 0   $ (20,282)
Ending balance (in shares) at Dec. 27, 2019   99,000              
Ending balance at Dec. 27, 2019 2,338,701   0 2,351,251 (18,060) 2,333,290 5,411    
Beginning balance (in shares) at Sep. 25, 2020   99,000              
Beginning balance at Sep. 25, 2020 2,438,405   0 2,443,138 (10,594) 2,432,643 5,762    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 142,690     135,198   135,198 7,492    
Other comprehensive income, net of tax 10,149       9,986 9,986 163    
Distributions to controlling interest (7,362)           (7,362)    
Stock-based compensation expense $ 26,313   26,313     26,313      
Shares repurchased (in shares) (450,399) 0              
Repurchase of common stock $ (39,985)   (49,550) 9,565   (39,985)      
Cash dividends declared and paid on common stock (22,231)     (22,231)   (22,231)      
Common stock issued under employee stock plans 51,323 $ 2 51,321     51,323      
Tax withholdings on vesting of restricted stock (in shares)               (1,000)  
Tax withholdings on vesting of restricted stock (28,085)       0 (28,085) 0   $ (28,084)
Ending balance (in shares) at Dec. 25, 2020   100,000              
Ending balance at Dec. 25, 2020 $ 2,571,217   $ 0 $ 2,565,670 $ (608) $ 2,565,162 $ 6,055